129 related articles for article (PubMed ID: 34810221)
21. A role for RUNX1 in hematopoiesis and myeloid leukemia.
Ichikawa M; Yoshimi A; Nakagawa M; Nishimoto N; Watanabe-Okochi N; Kurokawa M
Int J Hematol; 2013 Jun; 97(6):726-34. PubMed ID: 23613270
[TBL] [Abstract][Full Text] [Related]
22. Runx1 is essential at two stages of early murine B-cell development.
Niebuhr B; Kriebitzsch N; Fischer M; Behrens K; Günther T; Alawi M; Bergholz U; Müller U; Roscher S; Ziegler M; Buchholz F; Grundhoff A; Stocking C
Blood; 2013 Jul; 122(3):413-23. PubMed ID: 23704093
[TBL] [Abstract][Full Text] [Related]
23. Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.
Cheng CK; Chan NP; Wan TS; Lam LY; Cheung CH; Wong TH; Ip RK; Wong RS; Ng MH
Haematologica; 2016 Apr; 101(4):448-57. PubMed ID: 26802049
[TBL] [Abstract][Full Text] [Related]
24. CHD7 and Runx1 interaction provides a braking mechanism for hematopoietic differentiation.
Hsu J; Huang HT; Lee CT; Choudhuri A; Wilson NK; Abraham BJ; Moignard V; Kucinski I; Yu S; Hyde RK; Tober J; Cai X; Li Y; Guo Y; Yang S; Superdock M; Trompouki E; Calero-Nieto FJ; Ghamari A; Jiang J; Gao P; Gao L; Nguyen V; Robertson AL; Durand EM; Kathrein KL; Aifantis I; Gerber SA; Tong W; Tan K; Cantor AB; Zhou Y; Liu PP; Young RA; Göttgens B; Speck NA; Zon LI
Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23626-23635. PubMed ID: 32883883
[TBL] [Abstract][Full Text] [Related]
25. RUNX1B Expression Is Highly Heterogeneous and Distinguishes Megakaryocytic and Erythroid Lineage Fate in Adult Mouse Hematopoiesis.
Draper JE; Sroczynska P; Tsoulaki O; Leong HS; Fadlullah MZ; Miller C; Kouskoff V; Lacaud G
PLoS Genet; 2016 Jan; 12(1):e1005814. PubMed ID: 26808730
[TBL] [Abstract][Full Text] [Related]
26. Alternative Runx1 promoter usage in mouse developmental hematopoiesis.
Bee T; Liddiard K; Swiers G; Bickley SR; Vink CS; Jarratt A; Hughes JR; Medvinsky A; de Bruijn MF
Blood Cells Mol Dis; 2009; 43(1):35-42. PubMed ID: 19464215
[TBL] [Abstract][Full Text] [Related]
27. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
[TBL] [Abstract][Full Text] [Related]
28. Distinct mechanisms of regulation of the ITGA6 and ITGB4 genes by RUNX1 in myeloid cells.
Phillips JL; Taberlay PC; Woodworth AM; Hardy K; Brettingham-Moore KH; Dickinson JL; Holloway AF
J Cell Physiol; 2018 Apr; 233(4):3439-3453. PubMed ID: 28926098
[TBL] [Abstract][Full Text] [Related]
29. Redundant mechanisms driven independently by RUNX1 and GATA2 for hematopoietic development.
Bresciani E; Carrington B; Yu K; Kim EM; Zhen T; Guzman VS; Broadbridge E; Bishop K; Kirby M; Harper U; Wincovitch S; Dell'Orso S; Sartorelli V; Sood R; Liu P
Blood Adv; 2021 Dec; 5(23):4949-4962. PubMed ID: 34492681
[TBL] [Abstract][Full Text] [Related]
30. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells.
Klunker S; Chong MM; Mantel PY; Palomares O; Bassin C; Ziegler M; Rückert B; Meiler F; Akdis M; Littman DR; Akdis CA
J Exp Med; 2009 Nov; 206(12):2701-15. PubMed ID: 19917773
[TBL] [Abstract][Full Text] [Related]
31. Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia.
Jakobczyk H; Debaize L; Soubise B; Avner S; Rouger-Gaudichon J; Commet S; Jiang Y; Sérandour AA; Rio AG; Carroll JS; Wichmann C; Lie-A-Ling M; Lacaud G; Corcos L; Salbert G; Galibert MD; Gandemer V; Troadec MB
J Hematol Oncol; 2021 Mar; 14(1):47. PubMed ID: 33743795
[TBL] [Abstract][Full Text] [Related]
32. Overexpression or knock-down of runt-related transcription factor 1 affects BCR-ABL-induced proliferation and migration in vitro and leukemogenesis in vivo in mice.
Yang LJ; Yu WD; DU JB; Chao S; Chen MX; Zhao HH; Guo JZ
Chin Med J (Engl); 2009 Feb; 122(3):331-7. PubMed ID: 19236814
[TBL] [Abstract][Full Text] [Related]
33. T-cell receptor signaling induces proximal Runx1 transactivation via a calcineurin-NFAT pathway.
Wong WF; Looi CY; Kon S; Movahed E; Funaki T; Chang LY; Satake M; Kohu K
Eur J Immunol; 2014 Mar; 44(3):894-904. PubMed ID: 24310293
[TBL] [Abstract][Full Text] [Related]
34. Runx1 is a co-activator with FOXO3 to mediate transforming growth factor beta (TGFbeta)-induced Bim transcription in hepatic cells.
Wildey GM; Howe PH
J Biol Chem; 2009 Jul; 284(30):20227-39. PubMed ID: 19494111
[TBL] [Abstract][Full Text] [Related]
35. RUNX1 positively regulates a cell adhesion and migration program in murine hemogenic endothelium prior to blood emergence.
Lie-A-Ling M; Marinopoulou E; Li Y; Patel R; Stefanska M; Bonifer C; Miller C; Kouskoff V; Lacaud G
Blood; 2014 Sep; 124(11):e11-20. PubMed ID: 25082880
[TBL] [Abstract][Full Text] [Related]
36. Multifunctional reversible knockout/reporter system enabling fully functional reconstitution of the AML1/Runx1 locus and rescue of hematopoiesis.
Samokhvalov IM; Thomson AM; Lalancette C; Liakhovitskaia A; Ure J; Medvinsky A
Genesis; 2006 Mar; 44(3):115-21. PubMed ID: 16496309
[TBL] [Abstract][Full Text] [Related]
37. Early chromatin unfolding by RUNX1: a molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program.
Hoogenkamp M; Lichtinger M; Krysinska H; Lancrin C; Clarke D; Williamson A; Mazzarella L; Ingram R; Jorgensen H; Fisher A; Tenen DG; Kouskoff V; Lacaud G; Bonifer C
Blood; 2009 Jul; 114(2):299-309. PubMed ID: 19339695
[TBL] [Abstract][Full Text] [Related]
38. Runx1 deletion or dominant inhibition reduces Cebpa transcription via conserved promoter and distal enhancer sites to favor monopoiesis over granulopoiesis.
Guo H; Ma O; Speck NA; Friedman AD
Blood; 2012 May; 119(19):4408-18. PubMed ID: 22451420
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of RUNX3 Represses RUNX1 to Drive Transformation of Myelodysplastic Syndrome.
Yokomizo-Nakano T; Kubota S; Bai J; Hamashima A; Morii M; Sun Y; Katagiri S; Iimori M; Kanai A; Tanaka D; Oshima M; Harada Y; Ohyashiki K; Iwama A; Harada H; Osato M; Sashida G
Cancer Res; 2020 Jun; 80(12):2523-2536. PubMed ID: 32341038
[TBL] [Abstract][Full Text] [Related]
40. The artificial loss of Runx1 reduces the expression of quiescence-associated transcription factors in CD4(+) T lymphocytes.
Wong WF; Kohu K; Nagashima T; Funayama R; Matsumoto M; Movahed E; Tan GM; Yeow TC; Looi CY; Kurokawa M; Osato M; Igarashi K; Nakayama K; Satake M
Mol Immunol; 2015 Dec; 68(2 Pt A):223-33. PubMed ID: 26350416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
